Regeneron Pharmaceuticals, Inc. financial data

Symbol
REGN on Nasdaq
Location
777 Old Saw Mill River Road, Tarrytown, New York
State of incorporation
New York
Fiscal year end
December 31

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 544 % +7.3%
Quick Ratio 76.2 % +1.82%
Debt-to-equity 28 % -7.8%
Return On Equity 16.1 % -21.5%
Return On Assets 12.6 % -20.1%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 76.7B USD +23.7%
Weighted Average Number of Shares Outstanding, Basic 107M shares -0.37%
Weighted Average Number of Shares Outstanding, Diluted 114M shares +0.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 13.1B USD +7.76%
Research and Development Expense 4.44B USD +23.6%
Costs and Expenses 9.07B USD +22%
Operating Income (Loss) 4.05B USD -14.6%
Nonoperating Income (Expense) 152M USD +26.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.2B USD -13.6%
Income Tax Expense (Benefit) 246M USD -52.8%
Net Income (Loss) Attributable to Parent 3.95B USD -8.87%
Earnings Per Share, Basic 37.1 USD/shares -8.54%
Earnings Per Share, Diluted 34.8 USD/shares -9.03%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.73B USD -12.1%
Marketable Securities, Current 8.11B USD +75%
Accounts Receivable, after Allowance for Credit Loss, Current 5.67B USD +6.35%
Inventory, Net 2.58B USD +7.44%
Assets, Current 19.5B USD +22.6%
Deferred Income Tax Assets, Net 2.58B USD +49.4%
Property, Plant and Equipment, Net 3.7B USD +9.09%
Operating Lease, Right-of-Use Asset 78M USD +9.55%
Intangible Assets, Net (Excluding Goodwill) 1.04B USD +13.4%
Other Assets, Noncurrent 444M USD +32%
Assets 33.1B USD +13.2%
Accounts Payable, Current 607M USD +2.95%
Employee-related Liabilities, Current 618M USD +24.3%
Contract with Customer, Liability, Current 459M USD -3.98%
Liabilities, Current 3.42B USD +8.98%
Contract with Customer, Liability, Noncurrent 127M USD +81.5%
Operating Lease, Liability, Noncurrent 68.7M USD +23.1%
Other Liabilities, Noncurrent 854M USD +33.9%
Liabilities 7.11B USD +8.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -80.9M USD +66.1%
Retained Earnings (Accumulated Deficit) 27.3B USD +17%
Stockholders' Equity Attributable to Parent 26B USD +14.6%
Liabilities and Equity 33.1B USD +13.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.59B USD -8.39%
Net Cash Provided by (Used in) Financing Activities -1.79B USD -77.4%
Net Cash Provided by (Used in) Investing Activities -3.19B USD +15.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -382M USD -272%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.74B USD -12.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 73.1M USD +36.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 2.63B USD +47.4%
Operating Lease, Liability 87.7M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.11B USD -0.35%
Lessee, Operating Lease, Liability, to be Paid 103M USD
Operating Lease, Liability, Current 19M USD +53.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 24.1M USD
Deferred Income Tax Expense (Benefit) -838M USD -12.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.6M USD
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -835M USD -4.61%
Current Income Tax Expense (Benefit) 1.08B USD -14.5%
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 696M USD +28.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.4M USD
Operating Lease, Payments 22.5M USD +192%
Additional Paid in Capital 11.4B USD +14.1%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 7.7M USD +4.05%
Current Federal Tax Expense (Benefit) 668M USD -31%
Amortization of Intangible Assets 92.2M USD +145%
Depreciation, Depletion and Amortization 421M USD +23.3%
Deferred State and Local Income Tax Expense (Benefit) -6.5M USD -141%
Interest Expense 73M USD +22.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%